A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting ...

Genetic risk models and variant classification tools are refining breast cancer risk assessment by identifying high-risk ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

Breast cancer in young women is driven by more aggressive molecular and epidemiologic features and requires age-specific, multidisciplinary management that balances oncologic goals with fertility ...

Adjuvant giredestrant significantly improved invasive DFS vs. standard-of-care endocrine therapy in patients with early-stage ...

AT SABCS 2025, researchers presented surgical outcomes for patients who received 6 months of neoadjuvant endocrine therapy for ER-positive, HER2-negative breast cancer.

Metastatic breast cancer treatment with the combination of PCS6422 and capecitabine (NGC-Cap) may increase the cancer-killing ...

Women who receive risk-based breast cancer screening recommendations discussed those recommendations with their primary care ...

Breast cancer is the most common cancer in women around the world. It has been widely studied throughout history. In fact, research on breast cancer has helped pave the way for breakthroughs in other ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Caitlin Giddings and Coco ...

As supply chains continue to evolve, professionals in the industry are faced with the challenges and complexities of creating sustainable supply chains in their organizations. The need to gain ...

Liz Simmons is an education staff writer at Forbes Advisor. She has written about higher education and career development for various online publications since 2016. She earned a master’s degree in ...